P626: A PHASE 1 STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF BCL-2 INHIBITOR BGB-11417 IN ADULT PATIENTS WITH MATURE B-CELL MALIGNANCIES

التفاصيل البيبلوغرافية
العنوان:	P626: A PHASE 1 STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF BCL-2 INHIBITOR BGB-11417 IN ADULT PATIENTS WITH MATURE B-CELL MALIGNANCIES
المؤلفون:	Caixia LI, Jia Wei, Liu Peng, He Huang, Fei LI, Yujun Dong, Qingqing Cai, Shenmiao Yang, Xinyou Zhang, Hui Zhou, Lu Zhang, Zaixing Shi, Zhiyu Liang, Binghao Wu, Keshu Zhou, Depei Wu
المصدر:	HemaSphere, Vol 7, p e2710810 (2023)
بيانات النشر:	Wiley, 2023.
سنة النشر:	2023
المجموعة:	LCC:Diseases of the blood and blood-forming organs
مصطلحات موضوعية:	Diseases of the blood and blood-forming organs, RC633-647.5
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	2572-9241
Relation:	http://journals.lww.com/10.1097/01.HS9.0000969408.27108.10; https://doaj.org/toc/2572-9241
DOI:	10.1097/01.HS9.0000969408.27108.10
URL الوصول:	https://doaj.org/article/a2daa7690e3d4592909da070e972be97
رقم الأكسشن:	edsdoj.2daa7690e3d4592909da070e972be97
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	25729241
DOI:	10.1097/01.HS9.0000969408.27108.10